David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 294



41
TITLE: Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538](S0090825821005114)(10.1016/j.ygyno.2021.06.017)  Full Text
AUTHORS: Kimberly Levinson; Anna L Beavis; Christopher Purdy; Anne F Rositch; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally; Saketh R Guntupalli; Omar Ragab; Yi Chun Lee; David Scott Miller ; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le; Yovanni Casablanca; Laura L Holman; Steven E Waggoner; Amanda N Fader; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 163, ISSUE: 3
INDEXED IN: Scopus CrossRef: 2
IN MY: ORCID | CIÊNCIAVITAE
42
TITLE: Delayed time to surgery with hormonal treatment does not adversely impact outcomes in women with low-grade endometrioid endometrial cancer  Full Text
AUTHORS: Sydney Oesch; Eugenia Kakadiaris; David Scott Miller ; Matthew Carlson; Jessica Lee; Salvatore Lococo; Jayanthi Lea;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
43
TITLE: Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician’s choice (TPC).
AUTHORS: Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally E Baron-Hay; Isabelle Laure Ray-Coquard; Ronnie Shapira-Frommer; Yong Man Kim; Mary McCormack; Steven Bird; Vimalanand S Prabhu; Allison Martin Nguyen; Qi Zhao; Lea Dutta; Vicky Makker;
PUBLISHED: 2021, SOURCE: Journal of Clinical Oncology, VOLUME: 39, ISSUE: 15_suppl
INDEXED IN: CrossRef: 9
IN MY: ORCID | CIÊNCIAVITAE
44
TITLE: Is there a need for consultant team for bowel resection? An evaluation of surgical outcomes of bowel resection at time of ovarian cytoreductive surgery  Full Text
AUTHORS: Terrence Wong; Matthew Carlson; Jayanthi Lea; Salvatore Lococo; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
45
TITLE: O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors
AUTHORS: Makker, V; Colombo, N; Casado Herráez, A; Santin, A; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Banerjee, S; Monk, B; Ushijima, K; Penson, R; Kristeleit, R; Fabbro, M; Orlando, M; Mackay, H; Ren, M; Orlowski, R; Dutta, L; Lorusso, D;
PUBLISHED: 2021, SOURCE: Oral Abstracts
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
46
TITLE: O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Makker, V; Colombo, N; Casado Herráez, A; Santin, A; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Baron-Hay, S; Ray-Coquard, I; Shapira, R; Ushijima, K; Sakata, J; Yonemori, K; YM Kim; EM Guerra; UA Sanli; Mccormack, M; Huang, J; AD Smith;
PUBLISHED: 2021, SOURCE: Oral Abstracts
INDEXED IN: CrossRef: 5
IN MY: ORCID | CIÊNCIAVITAE
47
TITLE: Outcomes of ovarian cancer patients treated with platinum or non-platinum based chemotherapy after PARP inhibitor maintenance.
AUTHORS: Ralynn Brann; Kevin Michael Kremer; Matthew Carlson; Salvatore LoCoco; Jayanthi Sivasothy Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Journal of Clinical Oncology, VOLUME: 39, ISSUE: 15_suppl
INDEXED IN: CrossRef: 3
IN MY: ORCID | CIÊNCIAVITAE
48
TITLE: Ovarian cancer, version 2.2020
AUTHORS: Deborah K Armstrong; Ronald D Alvarez; Jamie N Bakkum Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee May Chen; Mihaela Cristea; Maria DeRosa; Eric L Eisenhauer; David M Gershenson; Heidi J Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E Konecny; Charles A Leath; Joyce Liu; Haider Mahdi; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David Scott Miller ; David M O'Malley; Sanja Percac Lima; Elena Ratner; Steven W Remmenga; Roberto Vargas; Theresa L Werner; Emese Zsiros; Jennifer L Burns; Anita M Engh; ...More
PUBLISHED: 2021, SOURCE: JNCCN Journal of the National Comprehensive Cancer Network, VOLUME: 19, ISSUE: 2
INDEXED IN: Scopus CrossRef: 329
IN MY: ORCID
49
TITLE: Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study  Full Text
AUTHORS: Ursula A Matulonis; Helen Q Huang; Virginia L Filiaci; Marcus Randall; Paul A DiSilvestro; Katherine M Moxley; Jeffrey M Fowler; Matthew A Powell; Nick M Spirtos; Krishnansu S Tewari; William E Richards; John M Nakayama; David G Mutch; David Scott Miller ; Daniela Matei; Lari B Wenzel;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology
INDEXED IN: Scopus CrossRef: 5
IN MY: ORCID | CIÊNCIAVITAE
50
TITLE: Perioperative risk factors and postoperative outcomes following pelvic exenterations for gynecologic versus non-gynecologic malignancies  Full Text
AUTHORS: Alyssa Mercadel; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 5 of 30. Total results: 294.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service